RT @RichardPAConway: 3 year results of SELECT-COMPARE study of upadacitinib. No evidence of a signal in cardiovascular e
Tweet Content
3 year results of SELECT-COMPARE study of upadacitinib. No evidence of a signal in cardiovascular events or cancer. Reassuring, but really need an ORAL-Surveillance style study of upadacitinib to be confident. Abstr#0828 #ACR21 @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off